FOTIVDA

Product NDC
45629-089
Requested package NDC
45629-089-01
11-digit product format
456290089
Labeler code
45629
Product ID
45629-089_c9661f6f-3568-4df6-bb6c-a461f9ae6e14
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tivozanib
Dosage form
CAPSULE
Route
ORAL
Labeler
AVEO Pharmaceuticals, Inc.
Application
NDA212904
Marketing category
NDA
Marketing start
2021-03-10
Substance
TIVOZANIB HYDROCHLORIDE
Active strength
.89 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N212904-001FOTIVDATIVOZANIB HYDROCHLORIDEEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10
N212904-002FOTIVDATIVOZANIB HYDROCHLORIDEEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10

Orange Book patents#

Current patent rows page 1 of 1 · 6 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N212904-00171667222028-11-16Drug substance, Drug product2021-04-06
N212904-001115043652039-11-05U-34762022-12-01
N212904-001127789442039-11-05U-46402026-11-10
N212904-00271667222028-11-16Drug substance, Drug product2021-04-06
N212904-002115043652039-11-05U-34762022-12-01
N212904-002127789442039-11-05U-46402026-11-10

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N212904-001NCE2026-03-10
N212904-002NCE2026-03-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 76 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10d4dbc9d85df4…
2026-10-15 13:18:302026-09N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10c2088c7a36db…
2026-10-15 13:18:302026-09N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10c2088c7a36db…
2026-09-14 22:38:342026-08N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-1084e616aacf4f…
2026-09-14 22:38:342026-08N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-1084e616aacf4f…
2026-08-18 06:07:402026-07N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10caaa826d4ba7…
2026-08-18 06:07:402026-07N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-1031067a03dcf5…
2025-08-23 18:47 UTC2025-08N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-106a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-1003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-1003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-102680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-102680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-105bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-105bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10d06236e962d9…
2024-10-29 15:01 UTC2024-10N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-1079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-1079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-10301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-10301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-101e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-101e350fbaab3a…
2024-05-31 18:47 UTC2024-05N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-108072bd15b7f6…
2024-05-31 18:47 UTC2024-05N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-108072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-105c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-105c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N212904-001FOTIVDAEQ 0.89MG BASECAPSULE / ORALRLD2021-03-105d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N212904-002FOTIVDAEQ 1.34MG BASECAPSULE / ORALRLD, RS2021-03-105d02ea3f76ae…

Observed Orange Book patent history#

Patent history page 1 of 5 · 196 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N212904-00171667222028-11-16Drug substance, Drug product2021-04-06d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-001115043652039-11-05U-34762022-12-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-001127789442039-11-05U-46402026-11-10d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-00271667222028-11-16Drug substance, Drug product2021-04-06d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-002115043652039-11-05U-34762022-12-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-002127789442039-11-05U-46402026-11-10d4dbc9d85df4…
2026-10-15 13:18:302026-09N212904-00171667222028-11-16Drug substance, Drug product2021-04-06c2088c7a36db…
2026-10-15 13:18:302026-09N212904-001115043652039-11-05U-34762022-12-01c2088c7a36db…
2026-10-15 13:18:302026-09N212904-00271667222028-11-16Drug substance, Drug product2021-04-06c2088c7a36db…
2026-10-15 13:18:302026-09N212904-002115043652039-11-05U-34762022-12-01c2088c7a36db…
2026-09-14 22:38:342026-08N212904-00171667222028-11-16Drug substance, Drug product2021-04-0684e616aacf4f…
2026-09-14 22:38:342026-08N212904-001115043652039-11-05U-34762022-12-0184e616aacf4f…
2026-09-14 22:38:342026-08N212904-00271667222028-11-16Drug substance, Drug product2021-04-0684e616aacf4f…
2026-09-14 22:38:342026-08N212904-002115043652039-11-05U-34762022-12-0184e616aacf4f…
2026-08-18 06:07:402026-07N212904-00171667222028-11-16Drug substance, Drug product2021-04-06caaa826d4ba7…
2026-08-18 06:07:402026-07N212904-001115043652039-11-05U-34762022-12-01caaa826d4ba7…
2026-08-18 06:07:402026-07N212904-00271667222028-11-16Drug substance, Drug product2021-04-06caaa826d4ba7…
2026-08-18 06:07:402026-07N212904-002115043652039-11-05U-34762022-12-01caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N212904-00171667222028-11-16Drug substance, Drug product2021-04-06011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212904-001115043652039-11-05U-34762022-12-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212904-00271667222028-11-16Drug substance, Drug product2021-04-06011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212904-002115043652039-11-05U-34762022-12-01011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-00168219872025-04-26U-3100Drug substance, Drug product2021-04-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-00171667222028-11-16Drug substance, Drug product2021-04-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-001115043652039-11-05U-34762022-12-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-00268219872025-04-26U-3100Drug substance, Drug product2021-04-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-00271667222028-11-16Drug substance, Drug product2021-04-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-002115043652039-11-05U-34762022-12-0131067a03dcf5…
2025-08-23 18:47 UTC2025-08N212904-00168219872025-04-26U-3100Drug substance, Drug product2021-04-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-00171667222028-11-16Drug substance, Drug product2021-04-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-001115043652039-11-05U-34762022-12-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-00268219872025-04-26U-3100Drug substance, Drug product2021-04-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-00271667222028-11-16Drug substance, Drug product2021-04-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-002115043652039-11-05U-34762022-12-016a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-00168219872025-04-26U-3100Drug substance, Drug product2021-04-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-00171667222028-11-16Drug substance, Drug product2021-04-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-001115043652039-11-05U-34762022-12-01fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-00268219872025-04-26U-3100Drug substance, Drug product2021-04-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-00271667222028-11-16Drug substance, Drug product2021-04-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-002115043652039-11-05U-34762022-12-01fd3edfee7708…

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 2 · 74 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10N212904-001NCE2026-03-10d4dbc9d85df4…
2026-11-14 07:37:172026-10N212904-002NCE2026-03-10d4dbc9d85df4…
2026-10-15 13:18:302026-09N212904-001NCE2026-03-10c2088c7a36db…
2026-10-15 13:18:302026-09N212904-002NCE2026-03-10c2088c7a36db…
2026-09-14 22:38:342026-08N212904-001NCE2026-03-1084e616aacf4f…
2026-09-14 22:38:342026-08N212904-002NCE2026-03-1084e616aacf4f…
2026-08-18 06:07:402026-07N212904-001NCE2026-03-10caaa826d4ba7…
2026-08-18 06:07:402026-07N212904-002NCE2026-03-10caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N212904-001NCE2026-03-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212904-002NCE2026-03-10011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-001NCE2026-03-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212904-002NCE2026-03-1031067a03dcf5…
2025-08-23 18:47 UTC2025-08N212904-001NCE2026-03-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212904-002NCE2026-03-106a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-001NCE2026-03-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212904-002NCE2026-03-10fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212904-001NCE2026-03-10b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212904-002NCE2026-03-10b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212904-001NCE2026-03-1003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212904-002NCE2026-03-1003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212904-001NCE2026-03-102680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212904-002NCE2026-03-102680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212904-001NCE2026-03-105bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212904-002NCE2026-03-105bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212904-001NCE2026-03-10d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212904-002NCE2026-03-10d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N212904-001NCE2026-03-10d06236e962d9…
2024-10-29 15:01 UTC2024-10N212904-002NCE2026-03-10d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212904-001NCE2026-03-1079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212904-002NCE2026-03-1079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212904-001NCE2026-03-10301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212904-002NCE2026-03-10301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212904-001NCE2026-03-101e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212904-002NCE2026-03-101e350fbaab3a…
2024-05-31 18:47 UTC2024-05N212904-001NCE2026-03-108072bd15b7f6…
2024-05-31 18:47 UTC2024-05N212904-002NCE2026-03-108072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212904-001NCE2026-03-105c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212904-002NCE2026-03-105c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N212904-001NCE2026-03-105d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N212904-002NCE2026-03-105d02ea3f76ae…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
FOTIVDA
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TIVOZANIB HYDROCHLORIDE.89 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8A9H4VK35ZInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
de77155c-ecf2-4f15-9758-21d271449d83Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9c90f50f-ee2c-4dd2-9565-428b003bafedProduct name120210903

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
EffectiveRelated label
2025-08-14These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-08-14These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-08-14These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-08-14These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-08-14These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-08-14These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2025-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-08-25These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-08-25These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-08-25These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-08-25These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-08-25These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-08-25These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021
2022-07-29These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ® (tivozanib) capsules, for oral use Initial U.S. Approval: 2021

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
45629-089-01FOTIVDA21 in 1 BOTTLE, PLASTICCAPSULE2113
45629-089-01FOTIVDA1 in 1 BAGCAPSULE113
45629-089-02FOTIVDA21 in 1 BOTTLE, PLASTICCAPSULE2113
45629-089-02FOTIVDA1 in 1 CARTONCAPSULE113

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
45629-089-01EA - Each45629-089acf24915-29fa-4967-b7df-790ca8ebabcb12021-04-08
45629-089-02EA - Each45629-089a68d41fc-e4f9-40b3-8277-a87d59e906fe12025-10-14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
45629-089FOTIVDA (TIVOZANIB) CAPSULE [AVEO PHARMACEUTICALS, INC.]7Current NDC, Legacy NDC, 4 package rows20250524_de77155c-ecf2-4f15-9758-21d271449d83.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FOTIVDATIVOZANIBAVEO Pharmaceuticals, Inc.de77155c-ecf2-4f15-9758-21d271449d832026-09-15Warnings, Adverse reactionsExact identifier
application applno (NDA): 212904
application number: NDA212904
ndc (package): 45629-089-01
ndc (product): 45629-089
ndc11 (package): 45629008901

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2534244FOTIVDA 0.89 MG Oral CapsulePSNde77155c-ecf2-4f15-9758-21d271449d8313
2534249FOTIVDA 1.34 MG Oral CapsulePSNde77155c-ecf2-4f15-9758-21d271449d8313
2534238tivozanib 0.89 MG Oral CapsulePSNde77155c-ecf2-4f15-9758-21d271449d8313
2534247tivozanib 1.34 MG Oral CapsulePSNde77155c-ecf2-4f15-9758-21d271449d8313
2534244tivozanib 0.89 MG Oral Capsule [Fotivda]SBDde77155c-ecf2-4f15-9758-21d271449d8313
2534249tivozanib 1.34 MG Oral Capsule [Fotivda]SBDde77155c-ecf2-4f15-9758-21d271449d8313
2534238tivozanib 0.89 MG Oral CapsuleSCDde77155c-ecf2-4f15-9758-21d271449d8313
2534247tivozanib 1.34 MG Oral CapsuleSCDde77155c-ecf2-4f15-9758-21d271449d8313
2534244Fotivda (as tivozanib hydrochloride 1 MG) 0.89 MG Oral CapsuleSYde77155c-ecf2-4f15-9758-21d271449d8313
2534249Fotivda (as tivozanib hydrochloride 1.5 MG) 1.34 MG Oral CapsuleSYde77155c-ecf2-4f15-9758-21d271449d8313
2534244Fotivda 0.89 MG Oral CapsuleSYde77155c-ecf2-4f15-9758-21d271449d8313
2534249Fotivda 1.34 MG Oral CapsuleSYde77155c-ecf2-4f15-9758-21d271449d8313
2534238tivozanib (as tivozanib hydrochloride 1 MG) 0.89 MG Oral CapsuleSYde77155c-ecf2-4f15-9758-21d271449d8313
2534247tivozanib (as tivozanib hydrochloride 1.5 MG) 1.34 MG Oral CapsuleSYde77155c-ecf2-4f15-9758-21d271449d8313

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
45629-089-014562900890124 BOTTLE, PLASTIC in 1 CARTON (45629-089-01) > 21 CAPSULE in 1 BOTTLE, PLASTIC2021-03-100000-00-00NoNoCurrent